Mixed Phenotype Acute Leukemia

general

An acute leukemia of ambiguous lineage. It is characterized by the presence of either separate populations of blasts of more than one lineage, or one population of blasts co-expressing markers of more than one lineage.

74

Centers

408

Active Trials

$615K

Cancer Funding

Specific Cancer Types(3)

Top Centers for Mixed Phenotype Acute Leukemia(74)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
89.8
2
NCI Comprehensive
High-Volume Research Center
80.4
3
NCI Comprehensive
High-Volume Research Center
76.7
4
NCI Comprehensive
High-Volume Research Center
75.6
5
NCI Comprehensive
High-Volume Research Center
73.6
672.8
7
NCI Comprehensive
High-Volume Research Center
72.7
8
High-Volume Research Center
72.3
9
NCI Comprehensive
Active Research Program
69.5
10
Active Research Program
69.5
11
NCI Comprehensive
Active Research Program
69.1
12
NCI Comprehensive
Active Research Program
68.5
13
NCI Clinical
Active Research Program
68.0
14
Active Research Program
68.0
15
NCI Comprehensive
Active Research Program
66.1
16
Active Research Program
65.9
17
NCI Comprehensive
Active Research Program
65.7
18
NCI Comprehensive
Active Research Program
63.0
19
NCI Clinical
Active Research Program
63.0
20
NCI Comprehensive
Active Research Program
62.8
21
Active Research Program
62.8
22
Active Research Program
62.8
23
NCI Comprehensive
Active Research Program
59.9
24
NCI Comprehensive
Active Research Program
59.9
25
NCI Comprehensive
Active Research Program
59.9
26
NCI Comprehensive
Active Research Program
58.0
27
NCI Comprehensive
Active Research Program
58.0
28
NCI Comprehensive
Active Research Program
58.0
29
NCI Comprehensive
Active Research Program
58.0
3058.0
31
Active Research Program
58.0
32
NCI Comprehensive
Active Research Program
51.3
33
NCI Comprehensive
Active Research Program
51.3
34
NCI Comprehensive
Active Research Program
51.3
35
Active Research Program
51.3
36
Active Research Program
51.3
37
Active Research Program
51.3
38
Active Research Program
51.3
39
Active Research Program
48.8
40
NCI Comprehensive
Active Research Program
46.3
41
NCI Comprehensive
Active Research Program
43.7
42
NCI Comprehensive
Active Research Program
43.7
43
NCI Comprehensive
Active Research Program
43.7
44
NCI Clinical
Active Research Program
43.7
45
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
43.7
46
NCI Clinical
Active Research Program
43.7
47
NCI Comprehensive
Active Research Program
43.7
48
Active Research Program
43.7
49
Active Research Program
43.7
5043.7
51
BC CancerVancouver, BC
Active Research Program
43.7
52
Active Research Program
43.7
53
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
38.5
54
NCI Comprehensive
Active Research Program
38.5
55
NCI Comprehensive
Active Research Program
38.5
56
NCI Comprehensive
Contributing Research Center
34.6
57
Cedars-Sinai CancerLos Angeles, CA
Contributing Research Center
34.6
58
Contributing Research Center
34.6
59
Stephenson Cancer CenterOklahoma City, OK
NCI Clinical
Contributing Research Center
34.6
60
NCI Comprehensive
Contributing Research Center
34.6
61
Contributing Research Center
34.6
62
Contributing Research Center
34.6
63
Contributing Research Center
34.6
64
NCI Comprehensive
Contributing Research Center
28.8
65
NCI Comprehensive
Contributing Research Center
28.8
66
NCI Comprehensive
Contributing Research Center
28.8
67
NCI Comprehensive
Contributing Research Center
28.8
68
NCI Comprehensive
Contributing Research Center
28.8
69
NCI Comprehensive
Contributing Research Center
28.8
70
NCI Comprehensive
Contributing Research Center
28.8
71
NCI Comprehensive
Contributing Research Center
28.8
72
Contributing Research Center
28.8
73
Contributing Research Center
28.8
7425.4

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →